PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2012 | 42 |
| 2013 | 112 |
| 2014 | 197 |
| 2015 | 211 |
| 2016 | 376 |
| 2017 | 301 |
| 2018 | 618 |
| 2019 | 869 |
| 2020 | 847 |
| 2021 | 795 |
| 2022 | 1025 |
| 2023 | 1252 |
| 2024 | 1096 |
| 2025 | 960 |
| 2026 | 908 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Cancer Med"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Pre-Existing and Post-Cancer Major Cardiovascular Disease and Their Association With Mortality Outcomes Among Cancer Survivors in Australia.
- Rahman MM, Bell K, Joshy G, David M, Canfell K, Goldsbury D, Koczwara B, Banks E, Negishi K, Delaney GP, Yap ML, Yu XQ.
- Cancer Med. 2026 Oct;15(10):e72413. doi: 10.1002/cam4.72413.
- PMCID: PMC13691301
Rahman MM, et al.Cancer Med. 2026.PMCID: PMC13691301 -
The Predictive Value of the Systemic Immune-Inflammation Index Combined With Clinical Stage for the Prognosis of Oesophageal Cancer Patients Treated With Radiotherapy: A Retrospective Cohort Study and Meta-Analysis.
- Ou Y, Liu Q, Yang D, Chen L, Yu J.
- Cancer Med. 2026 Oct;15(10):e72431. doi: 10.1002/cam4.72431.
- PMCID: PMC13691295
Ou Y, et al.Cancer Med. 2026.PMCID: PMC13691295 -
Eosinophil Dynamics May Help Differentiate Immune-Related From TKI-Related Adverse Events During IO-TKI Therapy for Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.
- Tomita M, Tasaki Y, Hamamoto S, Osawa T, Yamashita S, Matsumoto R, Ikoma H, Kawase K, Mimura Y, Sugiyama Y, Yasui T, Furukawa-Hibi Y.
- Cancer Med. 2026 Oct;15(10):e72422. doi: 10.1002/cam4.72422.
- PMCID: PMC13691297
Tomita M, et al.Cancer Med. 2026.PMCID: PMC13691297 -
Legal Frameworks, Institutional Barriers and Unmet Needs of Young University Students With Cancer in Italy: A Call to Action.
- Toss A, Marziali L, Quarello P, Milano GM, Mascarin M, Puccini A, Maruzzo M, Tornesello A, Spinelli M, Bertuzzi AF, Indini A, Perillo T, Baldi GG, Rosanu MN, Colombo C, Ferrari A, Peccatori FA.
- Cancer Med. 2026 Oct;15(10):e72414. doi: 10.1002/cam4.72414.
- PMCID: PMC13691298
Toss A, et al.Cancer Med. 2026.PMCID: PMC13691298 -
Quality Appraisal of Clinical Practice Guidelines in Psychosocial Oncology Using the AGREE-II Instrument.
- Bergeron C, Azzi M, Hébert C, Watkins-Martin K, Coroiu A, Loiselle CG, Drapeau M, Körner A.
- Cancer Med. 2026 Oct;15(10):e72403. doi: 10.1002/cam4.72403.
- PMCID: PMC13691292
Bergeron C, et al.Cancer Med. 2026.PMCID: PMC13691292 -
RAS-Pathway Mutation Profiles and Clinical Outcomes Among Patients With Colorectal Cancer.
- Kazemian E, Liu L, Waissengrin B, Matejcic M, Sobieski D, Tsai YY, Loroña NC, Nguyen NT, Oliveras Torres JA, Cress WD, Gordián ER, Siegel EM, Teer JK, Schmit SL, Figueiredo JC.
- Cancer Med. 2026 Oct;15(10):e72411. doi: 10.1002/cam4.72411.
- PMCID: PMC13691186
Kazemian E, et al.Cancer Med. 2026.PMCID: PMC13691186 -
Exploring Vitamin D Metabolism in Gynaecological Malignancies: Redox-Dependent and Redox-Independent Anticancer Mechanisms From Preclinical Models to Clinical Evidence.
- Chan HCC, Bhoora S, Zhou E, Marais S, Punchoo R.
- Cancer Med. 2026 Oct;15(10):e72292. doi: 10.1002/cam4.72292.
- PMCID: PMC13689537
Chan HCC, et al.Cancer Med. 2026.PMCID: PMC13689537 -
Apparent Survival Benefit of Postoperative Radioactive Iodine in Lymph Node-Positive Papillary Thyroid Carcinoma: A Negative-Control Analysis for Unmeasured Confounding.
- Liu T, Qiao J, Mao M, Guo Q, Yang F.
- Cancer Med. 2026 Oct;15(10):e72320. doi: 10.1002/cam4.72320.
- PMCID: PMC13688430
Liu T, et al.Cancer Med. 2026.PMCID: PMC13688430 -
Development and Feasibility Evaluation of a Nurse-Led ePRO System for Home-Based Post-Chemotherapy Symptom Management in Patients With Cancer.
- Kuan CC, Guo JC, Shen SH, Hsu C, Chu CM, Lin CK, Pan HH.
- Cancer Med. 2026 Oct;15(10):e72377. doi: 10.1002/cam4.72377.
- PMCID: PMC13688432
Kuan CC, et al.Cancer Med. 2026.PMCID: PMC13688432 -
Driver Gene Mutations Reprogram Lipid Metabolism in Non-Small Cell Lung Cancer.
- Lin J, Pang Z, Jiang Z, Li F.
- Cancer Med. 2026 Oct;15(10):e72334. doi: 10.1002/cam4.72334.
- PMCID: PMC13688421
Lin J, et al.Cancer Med. 2026.PMCID: PMC13688421